Rapid increase in serum lipid peroxide 4-hydroxynonenal (HNE) through monocyte NADPH oxidase in early endo-toxemia

Free Radical Research

Volumn 39, Issue 8, 2005, Pages 845-851

  Kimura, Hiroko ^a   Liu, Shuang ^b   Yamada, Satoshi ^c   Uchida, Koji ^d   Matsumoto, Kazuko ^e   Mukaida, Masahiro ^f   Yoshida, Ken Ichi ^b  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c NOF Corporation   (Japan)

^d NAGOYA UNIVERSITY   (Japan)

^e WASEDA UNIVERSITY   (Japan)

^f NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

4 Hydroxynonenal (HNE); Lipid peroxide; Lipo polysaccharide; NADPH oxidase; Time resolved fluoroimmunoassay

Indexed keywords

4 HYDROXYNONENAL; APOCYNIN; BACTERIUM LIPOPOLYSACCHARIDE; DIMETHYL SULFOXIDE; HYDROXYL RADICAL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SCAVENGER;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONTROLLED STUDY; ENDOTOXEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUOROIMMUNOASSAY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INTERMETHOD COMPARISON; LEUKOCYTE; LIPID PEROXIDATION; MALE; MONOCYTE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN FUNCTION; RAT; REVIEW; SENSITIVITY ANALYSIS;

ALDEHYDES; ANIMALS; BLOTTING, WESTERN; CARRIER PROTEINS; ENDOTOXEMIA; FLUOROIMMUNOASSAY; HUMANS; LEUKOCYTES, MONONUCLEAR; LIPID PEROXIDES; LIPOPOLYSACCHARIDES; MALE; MALONDIALDEHYDE; MICE; NADPH OXIDASE; RATS; RATS, SPRAGUE-DAWLEY; SENSITIVITY AND SPECIFICITY;

EID: 22144454310     PISSN: 10715762     EISSN: None     Source Type: Journal    
DOI: 10.1080/10715760500161546     Document Type: Review

References (39)

1. Stocker R, Keaney Jr., JF. Role of oxidative modifications in atherosclerosis. Physiol Rev 2004;84:1381-1478.
2. Chen J, Henderson GI, Freeman GL. Role of 4-hydroxynonenal in modification of cytochrome c oxidase in ischemia/reperfused rat heart. J Mol Cell Cardiol 2001;33: 1919-1927.
3. Toyokuni S, Yamada S, Kashima M, Ihara Y, Yamada Y, Tanaka T, Hiai H, Seino Y, Uchida K. Serum 4-hydroxy-2-nonenal-modified albumin is elevated in patients with type 2 diabetes mellitus. Antioxid Redox Signal 2000;2:681-685.
4. Hussein O, Shneider J, Rosenblat M, Aviram M. Valsartan therapy has additive anti-oxidative effect to that of fluvastatin therapy against low-density lipoprotein oxidation: Studies in hypercholesterolemic and hypertensive patients. J Cardiovasc Pharmacol 2002;40:28-34.
5. 2+ in rat liver microsomes. Biochem J 1982;208:129-140.
6. Benedetti A, Comporti M, Esterbauer H. Identification of 4-hydroxynonenal as a cytotoxic product originating from the peroxidation of liver microsomal lipids. Biochim Biophys Acta 1980;620:281-296.
7. Benedetti A, Pompella A, Fulceri R, Romani A, Comporti M. Detection of 4-hydroxynonenal and other lipid peroxidation products in the liver of bromobenzene-poisoned mice. Biochim Biophys Acta 1986;876:658-666.
8. Esterbauer H, Zollner H, Schaur RJ. Aldehydes forms by lipid peroxidation: Mechanisms formation, occurrence and determination. In: Vigo-Pelferey C, editor. Membrane Lipid Oxidation. Vol. 1. Boca Raton: CRC Press; 1990. p 239-268.
9. Childs A, Jacobs C, Kaminski T, Halliwell B, Leeuwenburgh C. Supplementation with vitamin C and N-acetyl-cysteine increases oxidative stress in humans after an acute muscle injury induced by eccentric exercise. Free Radic Biol Med 2001;31:745-753.
10. Fabris C, Pirisi M, Panozzo MP, Soardo G, Toniutto P, Hocza V, Bartoli E. Intensity of inflammatory damage and serum lipid peroxide concentrations in liver disease. J Clin Pathol 1993; 46:364-367.
11. Zuyderhoudt FM, Jorning GG, De Haan JG, Samson G, Van Gool J. Rat liver storage iron and plasma ferritin during D-galactosamine-HCl-induced hepatitis. Clin Sci (Lond) 1980; 58:321-325.
12. Sulpice T, Boucher F, Pucheu S, de Leiris J. Contribution of leukocyte infiltration to lipoperoxidation occurring in the non-ischemic region of the rat heart submitted to permanent left coronary artery occlusion. J Mol Cell Cardiol 1994;26:831-840.
13. Liu J, Yeo HC, Doniger SJ, Ames BN. Assay of aldehydes from lipid peroxidation: Gas chromatography-mass spectrometry compared to thiobarbituric acid. Anal Biochem 1997;245:161-166.
14. Karatas F, Karatepe M, Baysar A. Determination of free malondialdehyde in human serum by high-performance liquid chromatography. Anal Biochem 2002;311:76-79.
15. Rosiers CD, Rivest MJ, Boily MJ, Jette M, Carrobecohen A, Kumar A. Gas-chromatographic-mass spectrometric assay of tissue malondialdehyde, 4-hydroxynonenal, and othe aldehydes after their reduction to stable alcohols. Anal Biochem 1993;208:161-170.
16. Ben-Shaul V, Lomnitski L, Nyska A, Zurovsky Y, Bergman M, Grossman S. The effect of natural antioxidants, NAO and apocynin, on oxidative stress in the rat heart following LPS challenge. Toxicol Lett 2001;123:1-10.
17. Aniya Y, Koyama T, Miyagi C, Miyahira M, Inomata C, Kinoshita S, Ichiba T. Free Radical Scavenging and Hepatoprotective Actions of the Medicinal Herb, Crassocephalum crepidioides from the Okinawa Islands. Biol Pharm Bull 2005;28:19-23.
18. Minamiyama Y, Takemura S, Toyokuni S, Imaoka S, Funae Y, Hirohashi K, Yoshikawa T, Okada S. CYP3A induction aggravates endotoxemic liver injury via reactive oxygen species in male rats. Free Radic Biol Med 2004;37:703-712.
19. Uchida K, Szweda LI, Chae H-Z, Stadman ER. Immunohistchemical detection of 4-hydoroxynonenal protein adducts in oxidized hepatocytes. Proc Natl Acad Sci 1993;90: 8742-8746.
20. Yuan J, Matsumoto K, Kimura H. A new tetradentate β-diketonate-europium chelate that can be covalently bound to proteins for time-resolved fluoroimmunoassay. Anal Chem 1998;70:596-601.
21. Yuan J, Wang G, Kimura H, Matsumoto K. Highly sensitive time-resolved fluoroimmunoassay of human immunoglobulin E by using a new europium fluorescent chelate as a label. Anal Biochem 1997;254:283-287.
22. Toyokuni S, Uchida K. Publication of unexamined patent applications 1996., No. Hei8-168394
23. Srivastava S, Dixit BL, Cai J, Sharma S, Hurst HE, Bhatnagar A, Srivastava SK. Metabolism of lipid peroxidation product, 4-hydroxynonenal (HNE) in rat erythrocytes: Role of aldose reductase. Free Radic Biol Med 2000;29:642651.
24. Srivastava S, Conklin DJ, Liu SQ, Prakash N, Boor PJ, Srivastava SK, Bhatnagar A. Identification of biochemical pathways for the metabolism of oxidized low-density lipoprotein derived aldehyde-4-hydroxy trans-2-nonenal in vascular smooth muscle cells. Atherosclerosis 2001;158: 339-350.
25. Ben-Shaul V, Lomnitski L, Nyska A, Zurovsky Y, Bergman M, Grossman S. The effect of natural antioxidants, NAO and apocynin, on oxidative stress in the rat heart following LPS challenge. Toxicol Lett 2001;123(1):1-10.
26. Strohmaier H, Hinghofer-Szalkay H, Schaur RJ. Detection of 4-hydroxynonenal (HNE) as a physiological component in human plasma. J Lipid Mediat Cell Signal 1995;11:51-61.
27. Spies-Martin D, Sommerburg O, Langhans CD, Leichsenring M. Measurement of 4-hydroxynonenal in small volume blood plasma samples: Modification of a gas chromatographic-mass spectrometric method for clinical settings. J Chromatogr B Analyt Technol Biomed Life Sci 2002;774:231-239.
28. Yoshino K, Sano M, Fujita M, Tomita I. Studies on the formation of aliphatic aldehydes in the plasma and liver of vitamin E-deficient rats. Chem Pharm Bull (Tokyo) 1990;38:2212-2215.
29. Kumagai T, Matsukawa N, Kaneko Y, Kusumi Y, Mitsumata M, Uchida K. A lipid peroxidation-derived inflammatory mediator: Identification of 4-hydroxy-2-nonenal as a potential inducer of cyclooxygenase-2 in macrophages. J Biol Chem 2004;279:48389-48396.
30. Ishii T, Tatsuda E, Kumazawa S, Nakayama T, Uchida K. Molecular basis of enzyme inactivation by an endogenous electrophile 4-hydroxy-2-nonenal: Identification of modification sites in glyceraldehyde-3-phosphate dehydrogenase. Biochemistry 2003;42:3474-3480.
31. Minekura H, Kumagai T, Kawamoto Y, Nara F, Uchida K. 4-Hydroxy-2-nonenal is a powerful endogenous inhibitor of endothelial response. Biochem Biophys Res Commun 2001; 282:557-561.
32. Waeg G, Dimsity G, Esterbauer H. Monoclonal antibodies for detection of 4-hydroxynonenal modified proteins. Free Radic Res 1996;25:149-159.
33. Uchida K, Toyokuni S, Nishikawa K, Kawakishi S, Oda H, Hiai H, Stadtman ER. Michael addition-type 4-hydroxy-2-nonenal adducts in modified low-density lipoproteins: Markers for atherosclerosis. Biochemistry 1994;33:12487-12494.
34. Mouithys-Mickalad A, Deby-Dupont G, Mathy-Hartert M, Habraken Y, Nys M, Henrotin Y, Lamy M, Deby C. Effects of glucocorticoids on the respiratory burst of Chlamydia-primed THP-1 cells. Biochem Biophys Res Commun 2004;11: 941-948.
35. Aviram M, Rosenblat M, Etzioni A, Levy R. Activation of NADPH oxidase required for macrophage-mediated oxidation of low-density lipoprotein. Metabolism 1996;45:1069-1079.
36. Fortuno A, Olivan S, Beloqui O, San Jose G, MU, Diez J, Zalba G. Association of increased phagocytic NADPH oxidase-dependent superoxide production with diminished nitric oxide generation in essential hypertension. J Hypertens 2004;22:2169-2175.
37. Venugopal SK, Devaraj S, Yang T, Jialal I. Alpha-tocopherol decreases superoxide anion release in human monocytes under hyperglycemic conditions via inhibition of protein kinase C-alpha. Diabetes 2002;5:3049-3054.
38. Li W, Hellsten A, Jacobsson LS, Blomqvist HM, Olsson AG, Yuan XM. Alpha-tocopherol and astaxanthin decrease macrophage infiltration, apoptosis and vulnerability in atheroma of hyperlipidaemic rabbits. J Mol Cell Cardiol 2004;37:969-978.
39. Kumagai T, Matsukawa N, Kaneko Y, Kusumi Y, Mitsumata M, Uchida K. A lipid peroxidation-derived inflammatory mediator: Identification of 4-hydroxy-2-nonenal as a potential inducer of cyclooxygenase-2 in macrophages. J Biol Chem 2004;279:48389-48396.